AKARI THERAPEUTICS PLC-ADR (AKTX) Stock Analyst Ratings
USA - NASDAQ:AKTX - US00972G2075 - ADR
0.916 USD
-0.02 (-1.9%)
0.9 USD
-0.02 (-1.75%)
ChartMill assigns a Buy % Consensus number of 82% to AKTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.62. This target is 404.8% above the current price.
AKTX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AKTX.
In the previous month the buy percentage consensus was at a similar level.
AKTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-18 | Maxim Group | Initiate | Buy |
| 2022-12-05 | HC Wainwright & Co. | Initiate | Buy |
| 2022-11-01 | Alliance Global Partners | Initiate | Buy |